ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
4,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
4,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
7,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
8,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
8,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
8,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
9,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
10,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
11,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
12,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
13,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
13,2,Headache,Headaches NEC,Headaches,Nerv,N
13,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
15,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
15,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
15,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
16,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
16,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
17,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
17,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
20,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
21,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
22,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
22,2,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
23,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
24,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
24,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
25,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
26,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
26,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
28,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
29,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
30,1,Ligament rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
31,1,Headache,Headaches NEC,Headaches,Nerv,N
32,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
33,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
33,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
34,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
34,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
34,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
35,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
35,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
35,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
35,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
35,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
36,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
36,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
36,3,Lens disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
37,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
38,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
38,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
39,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
39,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
39,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
39,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
39,6,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
40,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
41,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
41,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
42,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
43,1,Meningitis listeria,Listeria infections,Bacterial infectious disorders,Infec,N
44,1,Headache,Headaches NEC,Headaches,Nerv,N
45,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
45,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
45,3,Headache,Headaches NEC,Headaches,Nerv,N
45,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
45,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
45,7,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
45,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
46,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
46,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
47,2,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
48,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
49,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
50,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
51,1,Double stranded DNA antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
52,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
53,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
54,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
54,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
54,3,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
54,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
54,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
55,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
56,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
56,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
56,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
56,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
58,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
59,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
59,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
59,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
60,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
61,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
61,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
61,3,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
62,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
63,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
63,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
63,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
64,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
65,1,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
66,1,Elephantiasis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
67,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
67,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
67,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
68,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
69,1,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
70,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
70,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
70,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
70,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
70,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
70,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
71,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
72,1,Effusion,General signs and symptoms NEC,General system disorders NEC,Genrl,N
72,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
72,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
72,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
73,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
73,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
73,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
74,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
74,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
74,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
74,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
74,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
74,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
74,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
75,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
76,1,Renal amyloidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
77,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
77,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
77,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
78,1,Phlebitis superficial,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
79,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
80,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
80,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
80,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
80,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
80,5,Vocal cord polyp,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
81,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
81,2,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
82,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
83,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
83,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
83,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
83,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
83,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
84,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
84,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
84,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
84,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
84,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
85,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
86,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
87,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
87,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
87,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
88,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
89,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
89,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
89,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
90,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
90,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
90,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
90,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
91,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
91,2,Migraine,Migraine headaches,Headaches,Nerv,N
92,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
92,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
93,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
93,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
94,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
94,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
94,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
94,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
95,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
95,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
96,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
96,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
96,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
96,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
97,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
97,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
97,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
98,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
98,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
99,1,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
100,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
100,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
101,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
102,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
102,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
103,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
103,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
104,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
105,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
106,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
106,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
106,3,Headache,Headaches NEC,Headaches,Nerv,N
106,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
107,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
107,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
107,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
108,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
109,1,Headache,Headaches NEC,Headaches,Nerv,N
109,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
110,1,Headache,Headaches NEC,Headaches,Nerv,N
110,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
111,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
112,1,Bladder leukoplakia,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
112,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
112,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
113,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
113,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
113,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
113,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
114,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
114,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
115,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
116,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
116,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
117,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
117,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
117,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
118,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
119,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
120,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
120,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
121,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
121,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
122,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
122,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
123,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
123,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
123,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
123,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
124,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
125,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
125,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
126,1,Headache,Headaches NEC,Headaches,Nerv,N
126,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
127,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
127,2,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
127,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
128,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
128,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
129,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
129,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
129,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
130,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
131,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
132,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
132,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
133,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
134,1,Acne,Acnes,Skin appendage conditions,Skin,N
134,2,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
135,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
136,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
137,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
138,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
138,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
138,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
138,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
138,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
138,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
138,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
139,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
139,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
140,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
140,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
140,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
140,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
140,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
140,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
140,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
141,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
141,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
141,3,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
141,4,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
141,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
141,6,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
141,7,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
141,8,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
141,9,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
141,10,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
141,11,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
141,12,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
141,13,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
141,14,Splenic infarction,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
141,15,Takayasu's arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
142,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
142,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
142,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
143,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
144,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
145,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
146,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
147,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
147,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
147,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
148,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
148,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
148,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
149,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
150,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
151,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
152,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
152,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
152,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
153,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
154,1,Headache,Headaches NEC,Headaches,Nerv,N
154,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
154,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
154,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
154,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
154,6,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
155,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
155,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
156,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
156,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
157,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
157,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
157,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
158,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
158,2,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
158,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
158,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
159,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
160,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
160,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
160,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
160,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
160,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
161,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
161,2,Venous occlusion,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
162,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
162,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
162,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
162,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
163,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
164,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
164,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
164,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
165,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
165,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
166,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
166,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
166,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
166,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
166,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
166,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
167,1,Abscess rupture,Infections NEC,Infections - pathogen unspecified,Infec,N
167,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
167,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
167,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
167,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
167,6,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
167,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
167,8,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
167,9,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
167,10,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
167,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
168,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
168,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
168,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
168,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
168,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
168,6,Headache,Headaches NEC,Headaches,Nerv,N
168,7,Mucosal pain,Mucosal findings abnormal,General system disorders NEC,Genrl,N
168,8,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
169,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
169,2,Abscess rupture,Infections NEC,Infections - pathogen unspecified,Infec,N
169,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
169,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
169,5,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
169,6,Diverticulum intestinal,Diverticula,Diverticular disorders,Gastr,N
169,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
170,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
170,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
170,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
170,4,Headache,Headaches NEC,Headaches,Nerv,N
170,5,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
170,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
171,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
171,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
171,3,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
171,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
172,1,Scarlet fever,Streptococcal infections,Bacterial infectious disorders,Infec,N
173,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
174,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
174,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
174,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
174,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
175,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
175,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
175,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
175,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
175,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
176,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
177,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
178,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
179,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
179,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
179,3,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
179,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
179,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
179,6,Headache,Headaches NEC,Headaches,Nerv,N
179,7,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
179,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
180,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
180,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
180,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
181,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
181,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
182,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
182,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
183,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
184,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
185,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
185,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
185,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
186,1,Bacteroides infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
186,2,Fournier's gangrene,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
186,3,Scrotal abscess,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
186,4,Scrotal pain,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
186,5,Scrotal swelling,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
187,1,Carotid artery occlusion,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
187,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
187,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
188,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
189,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
190,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
191,1,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
192,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
192,2,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
193,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
194,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
195,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
196,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
197,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
197,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
198,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
198,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
198,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
199,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
200,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
200,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
200,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
200,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
200,5,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
200,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
200,7,Streptococcus test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
200,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
202,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
202,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
203,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
203,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
203,3,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
203,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
204,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
204,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
204,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
204,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
205,1,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
205,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
206,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
207,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
207,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
207,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
207,4,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
207,5,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
207,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
208,1,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
209,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
211,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
212,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
212,2,Headache,Headaches NEC,Headaches,Nerv,N
212,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
212,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
213,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
213,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
213,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
214,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
214,2,Costovertebral angle tenderness,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
214,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,4,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
215,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
216,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
217,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
217,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
217,3,Headache,Headaches NEC,Headaches,Nerv,N
217,4,Systemic lupus erythematosus rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
218,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
218,2,Headache,Headaches NEC,Headaches,Nerv,N
218,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
218,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
218,5,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
219,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
219,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
220,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
220,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
220,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
220,4,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
220,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
220,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
220,7,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
220,8,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
220,9,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
220,10,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
220,11,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
221,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
221,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
222,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
222,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
222,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
222,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
223,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
224,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
225,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
226,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
227,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
227,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
228,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
229,1,Endocarditis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
230,1,Headache,Headaches NEC,Headaches,Nerv,N
230,2,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
230,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
230,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
231,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
231,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
231,3,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
232,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
233,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
234,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
234,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
234,3,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
235,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
235,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
236,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
236,2,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
236,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
237,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
237,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
237,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
238,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
239,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
239,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
239,3,Muscle abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
240,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
240,2,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
240,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
240,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
241,1,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
241,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
242,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
243,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
244,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
244,2,Costochondritis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
244,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
245,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
246,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
247,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
247,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
248,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
249,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
249,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
249,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
250,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
251,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
252,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
252,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
252,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
252,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
253,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
254,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
254,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
254,3,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
254,4,Haptoglobin decreased,Haem metabolism analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
254,5,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
255,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
255,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
256,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
256,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
257,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
257,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
257,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
257,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
257,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
258,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
258,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
258,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
258,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
259,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
259,2,Costochondritis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
259,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
259,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
260,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
261,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
262,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
263,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
263,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
264,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
265,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
265,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
266,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
267,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
268,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
269,1,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
270,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
271,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
271,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
272,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
273,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
274,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
275,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
275,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
275,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
276,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
277,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
277,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
278,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
278,2,Prostate cancer recurrent,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
279,1,Pyomyositis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
280,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
280,2,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
281,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
282,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
283,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
283,2,Headache,Headaches NEC,Headaches,Nerv,N
284,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
285,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
285,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
286,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
287,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
288,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
288,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
289,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
289,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
290,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
290,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
290,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
290,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
290,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
290,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
290,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
290,8,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
291,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
291,2,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
292,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
293,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
294,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
295,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
296,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
297,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
297,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
297,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
297,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
298,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
299,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
300,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
301,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
301,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
301,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
301,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
301,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
301,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
301,7,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
302,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
302,2,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
303,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
304,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
304,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
305,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
306,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
306,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
306,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
306,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
306,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
306,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
307,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
308,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
309,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
310,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
311,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
311,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
311,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
312,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
313,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
313,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
314,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
315,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
316,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
317,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
318,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
318,2,Headache,Headaches NEC,Headaches,Nerv,N
319,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
320,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
321,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
322,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
323,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
323,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
324,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
325,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
326,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
326,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
327,1,Migraine,Migraine headaches,Headaches,Nerv,N
327,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
328,1,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
328,2,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
329,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
330,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
331,1,Headache,Headaches NEC,Headaches,Nerv,N
331,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
332,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
333,1,Brain neoplasm malignant,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
334,1,Vascular stent occlusion,Vascular complications associated with device,Complications associated with device,Genrl,N
335,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
335,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
335,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
335,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
336,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
337,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
337,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
337,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
337,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
337,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
337,6,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
337,7,Immobile,Disability issues,Lifestyle issues,SocCi,N
337,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
337,9,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
337,10,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
337,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
337,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
337,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
337,14,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
337,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
337,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
337,17,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
337,18,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
337,19,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
337,20,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
337,21,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
338,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
338,2,Headache,Headaches NEC,Headaches,Nerv,N
338,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
339,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
339,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
339,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
340,1,Coarctation of the aorta,Great vessel disorders congenital,Cardiac and vascular disorders congenital,Cong,N
340,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
340,3,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
340,4,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
341,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
341,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
342,1,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
343,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
343,2,Human epidermal growth factor receptor decreased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
343,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
343,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
344,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
345,1,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
345,2,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
345,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
346,1,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
346,2,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
347,1,Bronchopulmonary aspergillosis allergic,Aspergillus infections,Fungal infectious disorders,Infec,N
348,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
349,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
349,2,Septic arthritis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
349,3,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
350,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
350,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
350,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
351,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
352,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
352,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
353,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
354,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
354,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
354,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
355,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
356,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
356,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
357,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
357,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
357,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
358,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
359,1,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
360,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
360,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
360,3,Infusion site coldness,Infusion site reactions,Administration site reactions,Genrl,N
360,4,Infusion site hypoaesthesia,Infusion site reactions,Administration site reactions,Genrl,N
360,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
361,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
362,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
362,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
362,3,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
363,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
363,2,Headache,Headaches NEC,Headaches,Nerv,N
363,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
363,4,Scintillating scotoma,Visual disorders NEC,Vision disorders,Eye,N
364,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
365,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
365,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
365,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
365,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
366,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
367,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
368,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
368,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
368,3,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
369,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
369,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
370,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
370,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
371,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
372,1,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
373,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
374,1,Eczema nummular,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
374,2,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
374,3,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
374,4,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
374,5,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
374,6,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
375,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
376,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
377,1,Tonsil cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
378,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
378,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
379,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
379,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
379,3,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
380,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
380,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
381,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
382,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
382,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
382,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
383,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
383,2,Fournier's gangrene,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
384,1,Bladder transitional cell carcinoma,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
385,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
386,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
386,2,Lipids abnormal,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
387,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
388,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
388,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
388,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
388,4,Headache,Headaches NEC,Headaches,Nerv,N
388,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
388,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
388,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
389,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
390,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
390,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
390,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
390,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
391,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
392,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
393,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
394,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
394,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
394,3,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
395,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
396,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
397,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
398,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
399,1,Headache,Headaches NEC,Headaches,Nerv,N
400,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
401,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
401,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
401,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
402,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
402,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
402,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
403,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
404,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
404,2,Carotid artery stenosis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
404,3,Hemianopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
404,4,Ophthalmic migraine,Migraine headaches,Headaches,Nerv,N
404,5,Scintillating scotoma,Visual disorders NEC,Vision disorders,Eye,N
404,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
405,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
405,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
406,1,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
406,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
406,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
407,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
408,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
409,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
409,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
410,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
410,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
410,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
410,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
410,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
411,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
412,1,Rheumatoid nodule,Rheumatoid arthropathies,Joint disorders,Musc,N
413,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
414,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
414,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
415,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
415,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
416,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
416,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
416,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
416,4,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
416,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
417,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
418,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
418,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
418,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
418,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
418,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
418,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
418,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
419,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
420,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
421,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
421,2,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
421,3,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
421,4,Confabulation,Thinking disturbances,Disturbances in thinking and perception,Psych,N
421,5,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
421,6,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
421,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
421,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
421,9,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
421,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
421,11,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
421,12,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
421,13,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
421,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
422,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
423,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
424,1,Mesothelioma,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,N
425,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
426,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
426,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
427,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
428,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
428,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
428,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
429,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
430,1,Muscle abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
431,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
431,2,Headache,Headaches NEC,Headaches,Nerv,N
431,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
431,4,Migraine,Migraine headaches,Headaches,Nerv,N
431,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
431,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
431,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
431,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
431,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
432,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
433,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
433,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
434,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
435,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
435,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
435,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
435,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
436,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
437,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
437,2,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
437,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
437,4,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
437,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
437,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
437,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
438,1,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
438,2,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
439,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
439,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
439,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
439,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
439,5,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
439,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
439,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
440,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
440,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
440,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
441,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
442,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
443,1,Tonsil cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
444,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
444,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
445,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
445,2,Disability,Disability issues,Lifestyle issues,SocCi,N
445,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
445,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
445,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
446,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
447,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
447,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
448,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
449,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
449,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
450,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
450,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
451,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
451,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
451,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
451,4,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
452,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
452,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
452,3,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
452,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
452,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
452,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
453,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
453,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
453,3,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
454,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
455,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
455,2,Aspergilloma,Aspergillus infections,Fungal infectious disorders,Infec,N
455,3,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
455,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
455,5,Diverticulum intestinal,Diverticula,Diverticular disorders,Gastr,N
455,6,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
455,7,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
455,8,Large intestinal stenosis,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
455,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
455,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
456,1,Glioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
457,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
457,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
457,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
457,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
458,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
458,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
458,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
458,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
458,5,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
458,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
459,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
460,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
460,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
461,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
462,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
462,2,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
462,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
462,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
462,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
463,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
463,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
463,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
463,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
463,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
464,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
465,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
465,2,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
466,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
466,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
467,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
468,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
469,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
469,2,Renal amyloidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
470,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
470,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
470,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
471,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
472,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
472,2,CNS ventriculitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
472,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
472,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
472,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
472,6,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
473,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
473,2,Injection site paraesthesia,Injection site reactions,Administration site reactions,Genrl,N
473,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
473,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
473,5,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
474,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
474,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
475,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
476,1,Septic arthritis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
476,2,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
477,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
477,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
478,1,Rectal adenocarcinoma,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
479,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
480,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
481,1,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
481,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
482,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
483,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
484,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
484,2,Calculus urinary,Urinary tract lithiasis NEC,Urolithiases,Renal,N
484,3,Headache,Headaches NEC,Headaches,Nerv,N
484,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
484,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
484,6,Viral labyrinthitis,Viral infections NEC,Viral infectious disorders,Infec,N
485,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
486,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
486,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
487,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
487,2,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
488,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
488,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
488,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
488,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
488,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
488,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
489,1,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
490,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
490,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
491,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
492,1,Bladder transitional cell carcinoma,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
493,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
494,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
494,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
495,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
496,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
496,2,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
496,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
497,1,Gastric perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
498,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
498,2,Headache,Headaches NEC,Headaches,Nerv,N
499,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
500,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
500,2,Haemorrhoidal haemorrhage,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
501,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
501,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
501,3,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
501,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
501,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
501,6,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
502,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
502,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
502,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
502,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
503,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
503,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
503,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
504,1,Bladder neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
504,2,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
505,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
505,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
505,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
505,4,Neonatal hypoxia,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
506,1,Perinephric abscess,Urinary tract infections,Infections - pathogen unspecified,Infec,N
506,2,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
506,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
506,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
507,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
507,2,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
507,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
508,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
509,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
510,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
510,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
511,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
511,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
511,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
512,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
513,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
513,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
513,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
514,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
514,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
515,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
515,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
515,3,Headache,Headaches NEC,Headaches,Nerv,N
516,1,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
516,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
517,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
517,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
517,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
517,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
517,5,Perineal ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
518,1,Peripheral artery occlusion,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
518,2,Peripheral artery occlusion,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
518,3,Peripheral artery stenosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
519,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
519,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
519,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
519,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
519,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
520,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
521,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
521,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
521,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
522,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
522,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
522,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
522,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
523,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
524,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
525,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
526,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
527,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
528,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
528,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
529,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
530,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
530,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
530,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
530,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
530,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
531,1,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
532,1,Neurological infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
533,1,Arrhythmia supraventricular,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
533,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
534,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
535,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
535,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
536,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
537,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
537,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
537,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
537,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
537,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
538,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
538,2,Hypofibrinogenaemia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
539,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
540,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
540,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
540,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
541,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
542,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
542,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
543,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
544,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
544,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
544,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
544,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
545,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
545,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
546,1,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
546,2,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
546,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
547,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
547,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
548,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
548,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
548,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
548,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
549,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
550,1,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
551,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
552,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
552,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
553,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
554,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
554,2,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
554,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
554,4,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
555,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
555,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
555,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
555,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
555,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
556,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
556,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
557,1,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
557,2,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
558,1,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
559,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
560,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
561,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
562,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
562,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
563,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
564,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
565,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
566,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
566,2,Pelvic inflammatory disease,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
567,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
568,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
568,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
569,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
569,2,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
569,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
569,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
569,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
570,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
570,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
571,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
572,1,Fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
572,2,Muscle abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
572,3,Septic embolus,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
572,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
573,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
573,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
574,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
574,2,Fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
574,3,Septic embolus,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
574,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
575,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
575,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
576,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
577,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
578,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
579,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
579,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
580,1,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
580,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
581,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
581,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
582,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
582,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
583,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
584,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
584,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
584,3,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
584,4,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
585,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
585,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
585,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
586,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
587,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
588,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
589,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
589,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
590,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
590,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
590,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
591,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
591,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
591,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
591,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
592,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
592,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
593,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
593,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
594,1,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
594,2,Urinary tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
595,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
595,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
596,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
597,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
597,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
597,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
597,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
597,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
597,6,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
597,7,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
597,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
598,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
599,1,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
600,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
601,1,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
602,1,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
603,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
603,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
604,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
604,2,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
604,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
604,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
604,5,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
604,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
605,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
605,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
606,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
606,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
607,1,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
608,1,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
609,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
610,1,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
611,1,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
612,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
613,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
614,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
615,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
616,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
616,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
616,3,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
616,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
617,1,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
618,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
619,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
620,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
620,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
620,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
621,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
621,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
621,3,Pulmonary function test abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
621,4,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
621,5,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
622,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
623,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
624,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
624,2,Cyclic neutropenia,Neutropenias,White blood cell disorders,Blood,N
624,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
625,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,Y
626,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
627,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
628,1,C-reactive protein decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
628,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
628,3,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
629,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
629,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
629,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
630,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
631,1,Intestinal polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
632,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
632,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
632,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
632,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
633,1,Neovascular age-related macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
634,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
635,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
636,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
637,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
637,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
637,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
637,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
637,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
637,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
637,7,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
637,8,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
637,9,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
637,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
637,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
637,12,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
637,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
637,14,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
637,15,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
637,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
638,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
638,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
639,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
639,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
640,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
640,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
641,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
641,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
641,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
641,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
642,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
642,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
642,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
642,4,Headache,Headaches NEC,Headaches,Nerv,N
642,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
642,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
642,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
643,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
643,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
643,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
644,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
645,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
646,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
646,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
647,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
647,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
647,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
648,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
649,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
650,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
651,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
651,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
651,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
652,1,Headache,Headaches NEC,Headaches,Nerv,N
653,1,Aneurysm ruptured,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
653,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
654,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
654,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
654,3,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
654,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
654,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
654,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
655,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
655,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
655,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
656,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
657,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
657,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
657,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
657,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
657,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
657,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
658,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
658,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
659,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
659,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
659,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
659,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
660,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
661,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
661,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
661,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
662,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
662,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
663,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
664,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
664,2,Tubo-ovarian abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
665,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
665,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
665,3,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
666,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
666,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
667,1,Biopsy skin abnormal,Skin histopathology and skin investigations NEC,Skin investigations,Inv,N
667,2,Lyme disease,Borrelial infections,Bacterial infectious disorders,Infec,N
667,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
668,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
668,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
669,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
669,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
669,3,Headache,Headaches NEC,Headaches,Nerv,N
669,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
669,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
669,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
670,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
671,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
671,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
672,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
673,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
673,2,Lesion excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
674,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
675,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
675,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
676,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
677,1,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
678,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
679,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
680,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
681,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
682,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
682,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
682,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
682,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
683,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
683,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
683,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
684,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
685,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
685,2,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
686,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
686,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
687,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
687,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
687,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
687,4,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
687,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
687,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
687,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
687,8,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
688,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
688,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
689,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
690,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
691,1,Complement factor C3 decreased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
691,2,Complement factor C4 decreased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
691,3,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
691,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
692,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
692,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
693,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
694,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
695,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
696,1,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
697,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
697,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
697,3,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
697,4,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
698,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
698,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
698,3,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
699,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
700,1,Complement factor C4 decreased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
700,2,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
700,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
700,4,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
701,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
702,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
702,2,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
702,3,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
702,4,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
703,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
704,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
705,1,Central nervous system necrosis,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
706,1,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
706,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
706,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
706,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
707,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
708,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
709,1,Exostosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
709,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
710,1,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
711,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
712,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
713,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
713,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
713,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
713,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
714,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
715,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
716,1,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
716,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
716,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
717,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
717,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
717,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
718,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
718,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
718,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
718,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
718,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
718,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
718,7,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
718,8,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
718,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
719,1,Conductive deafness,Hearing losses,Hearing disorders,Ear,N
719,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
720,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
720,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
720,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
721,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
722,1,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
723,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
723,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
723,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
724,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
725,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
726,1,Basal ganglia infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
726,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
727,1,Breast cancer stage I,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
728,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
728,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
729,1,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
730,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
731,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
732,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
733,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
734,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
734,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
734,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
735,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
736,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
737,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
738,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
738,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
739,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
740,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
740,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
740,3,Hypergammaglobulinaemia benign monoclonal,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
740,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
741,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
741,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
742,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
742,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
742,3,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
743,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
744,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
744,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
745,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
745,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
745,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
745,4,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
746,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
747,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
748,1,Extradural abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
749,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
750,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
750,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
751,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
752,1,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
753,1,Ovarian cancer stage IV,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
754,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
754,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
755,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
756,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
757,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
757,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
758,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
758,2,Meningitis listeria,Listeria infections,Bacterial infectious disorders,Infec,Y
758,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
758,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
758,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
758,6,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
758,7,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
759,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
760,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
760,2,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
761,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
761,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
762,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
763,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
763,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
764,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
765,1,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
765,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
765,3,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
765,4,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
765,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
765,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
766,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
767,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
768,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
769,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
769,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
769,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
769,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
769,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
770,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
770,2,Headache,Headaches NEC,Headaches,Nerv,N
770,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
770,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
771,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
772,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
772,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
772,3,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
772,4,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
772,5,Spinal cord oedema,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
772,6,Zoonotic bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
773,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
773,2,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
773,3,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
774,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
775,1,Concomitant disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
775,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
775,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
776,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
776,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
776,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
777,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
778,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
778,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
778,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
778,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
779,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
779,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
779,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
779,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
780,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
781,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
781,2,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
782,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
782,2,Hyperintensity in brain deep nuclei,Structural brain disorders NEC,Structural brain disorders,Nerv,N
783,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
783,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
784,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
785,1,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
785,2,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
786,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
786,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
786,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
786,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
786,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
786,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
786,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
787,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
787,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
787,3,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
787,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
787,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
787,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
787,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
787,8,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
788,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
788,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
788,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
788,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
789,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
789,2,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
789,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
789,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
789,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
789,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
789,7,Viral haemorrhagic cystitis,Viral infections NEC,Viral infectious disorders,Infec,N
790,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
790,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
790,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
790,4,Serum amyloid A protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
791,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
791,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
791,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
791,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
792,1,Chillblains,Conditions caused by cold,Injuries by physical agents,Inj&P,N
793,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
793,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
793,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
793,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
794,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
794,2,Growth failure,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
794,3,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
794,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
794,5,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
794,6,Serum amyloid A protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
794,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
795,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
795,2,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
796,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
796,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
797,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
798,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
799,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
799,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
799,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
799,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
800,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
801,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
802,1,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
803,1,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
803,2,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
804,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
805,1,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
806,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
807,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
807,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
808,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
809,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
809,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
809,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
809,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
810,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
810,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
810,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
811,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
812,1,Colonic abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
812,2,Defaecation disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
812,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
812,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
813,1,Headache,Headaches NEC,Headaches,Nerv,N
813,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
814,1,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
814,2,Small intestinal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
815,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
816,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
817,1,Arterial occlusive disease,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
817,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
818,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
818,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
819,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
820,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
821,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
822,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
822,2,Neuromyelitis optica spectrum disorder,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
823,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
823,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
824,1,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
824,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
825,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
825,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
825,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
826,1,Complement factor C4 decreased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
827,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
828,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
828,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
828,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
829,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
829,2,Necrotic lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
830,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
831,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
832,1,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
833,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
834,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
834,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
834,3,Headache,Headaches NEC,Headaches,Nerv,N
835,1,Abscess rupture,Infections NEC,Infections - pathogen unspecified,Infec,N
835,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
835,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
836,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
836,2,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
837,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
838,1,Peyronie's disease,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
839,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
839,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
839,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
839,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
840,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
840,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
841,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
841,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
842,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
842,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
843,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
844,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
844,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
844,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
844,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
845,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
845,2,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
846,1,Arterial occlusive disease,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
846,2,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
846,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
846,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
846,5,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
846,6,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
846,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
847,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
847,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
847,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
848,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
849,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
849,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
850,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
851,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
851,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
852,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
853,1,Headache,Headaches NEC,Headaches,Nerv,N
853,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
853,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
853,4,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
853,5,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
853,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
854,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,Y
855,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
856,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
856,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
856,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
856,4,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
857,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
858,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
859,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
859,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
860,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
860,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
860,3,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
860,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
860,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
860,6,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
860,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
860,8,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
861,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
861,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
861,3,Death,Death and sudden death,Fatal outcomes,Genrl,N
861,4,Headache,Headaches NEC,Headaches,Nerv,N
861,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
861,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
861,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
862,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
863,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
864,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
864,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
864,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
864,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
864,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
864,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
865,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
865,2,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
866,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
867,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
867,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
868,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
868,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
868,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
868,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
869,1,Ovarian cancer stage I,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
870,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
870,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
871,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
871,2,Juvenile psoriatic arthritis,Psoriatic arthropathies,Joint disorders,Musc,N
871,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
871,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
872,1,Eye infection syphilitic,Treponema infections,Bacterial infectious disorders,Infec,N
873,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
873,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
874,1,Headache,Headaches NEC,Headaches,Nerv,N
875,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
876,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
876,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
876,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
876,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
876,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
877,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
877,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
877,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
878,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
878,2,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
878,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
878,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
878,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
879,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
879,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
879,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
880,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
880,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
880,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
881,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
881,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
881,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
882,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
883,1,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
884,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
884,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
885,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
885,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
886,1,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
887,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
887,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
888,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
888,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
888,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
888,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
888,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
888,6,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
889,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
889,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
889,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
890,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
890,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
891,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
891,2,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
892,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
892,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
892,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
892,4,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
892,5,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
892,6,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
893,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,Y
894,1,Headache,Headaches NEC,Headaches,Nerv,N
895,1,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
896,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
896,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
896,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
897,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
897,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
898,1,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
898,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
898,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
899,1,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
900,1,Malignant neoplasm of unknown primary site,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
901,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
901,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
901,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
902,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
903,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
904,1,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
904,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
905,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
906,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
906,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
906,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
907,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
908,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
909,1,Hypomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
909,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
910,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
911,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
912,1,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
912,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
912,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
912,4,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
912,5,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
912,6,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
912,7,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
913,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
913,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
914,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
914,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
914,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
914,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
915,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
916,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
916,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
916,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
917,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
918,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
918,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
918,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
918,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
919,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
920,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
920,2,Headache,Headaches NEC,Headaches,Nerv,N
920,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
920,4,Pulmonary artery aneurysm,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
920,5,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
921,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
922,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
922,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
923,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
923,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
923,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
924,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
924,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
925,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
925,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
925,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
925,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
925,5,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
925,6,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
926,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
927,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
928,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
929,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
930,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
931,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
932,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
933,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
934,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
934,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
934,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
934,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
935,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
936,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
936,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
936,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
936,4,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
936,5,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
937,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
937,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
937,3,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
937,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
938,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
938,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
939,1,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
939,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
939,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
940,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
940,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
941,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
941,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
941,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
941,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
942,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
942,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
942,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
943,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
943,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
943,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
943,4,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
944,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
945,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
946,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
946,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
946,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
946,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
947,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
947,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
947,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
947,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
947,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
947,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
947,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
947,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
947,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
947,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
948,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
948,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
948,3,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
949,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
950,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
950,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
950,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
951,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
951,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
951,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
951,4,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
952,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
952,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
952,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
952,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
952,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
952,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
952,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
952,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
952,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
953,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
953,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
954,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
954,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
954,3,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
955,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
956,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
956,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
956,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
956,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
956,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
957,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
958,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
959,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
959,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
960,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
960,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
960,3,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
960,4,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
961,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
962,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
962,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
962,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
962,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
963,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
963,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
963,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
964,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
965,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
966,1,Aspergilloma,Aspergillus infections,Fungal infectious disorders,Infec,N
967,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
968,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
969,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
969,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
970,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
971,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
971,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
971,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
972,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
972,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
973,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
973,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
973,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
973,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
973,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
973,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
973,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
973,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
973,9,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
974,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
974,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
974,3,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
974,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
974,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
974,6,Sudden cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
975,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
975,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
976,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
977,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
977,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
978,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
978,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
978,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
979,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
979,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
980,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
981,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
982,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
983,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
984,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
984,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
984,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
984,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
985,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
986,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
986,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
986,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
986,4,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
986,5,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
987,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
988,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
988,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
989,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
990,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
990,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
991,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
992,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
993,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
993,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
993,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
993,4,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
993,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
994,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
994,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
995,1,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
995,2,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
996,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
997,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
997,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
998,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
999,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
1000,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1001,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1002,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1003,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,Y
1004,1,Coronavirus pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
1004,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1004,3,Raoultella ornithinolytica infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1005,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1005,2,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1005,3,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1005,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1006,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1007,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1008,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1008,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1009,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1009,2,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1009,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1010,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1010,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1010,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1011,1,Peripheral nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
1012,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1013,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1013,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1014,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1015,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1015,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1016,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1017,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1017,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1017,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1018,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1018,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1018,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1019,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1019,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1020,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1020,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1020,3,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1020,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1020,5,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1021,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1021,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1021,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1022,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1022,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1022,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1022,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1022,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1022,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1022,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1022,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1022,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1022,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1023,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1024,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1024,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1024,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1025,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1025,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1025,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1025,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1025,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1026,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1027,1,Procedural anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1028,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1028,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1028,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1028,4,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1028,5,Headache,Headaches NEC,Headaches,Nerv,N
1028,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1028,7,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1028,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1028,9,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1029,1,Blood triglycerides abnormal,Triglyceride analyses,Lipid analyses,Inv,N
1029,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1030,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1031,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1032,1,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1033,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1033,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1034,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1035,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1035,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1035,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1036,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1036,2,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
1036,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1036,4,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1037,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1038,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1039,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1039,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1040,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1041,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1041,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1041,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1041,4,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1042,1,Allergy to vaccine,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1043,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1044,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1044,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1044,3,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1044,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1045,1,Oligomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1046,1,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1046,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1047,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1048,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1049,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1050,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1051,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1052,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1053,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1054,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1055,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1056,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1057,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1057,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1057,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1057,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1057,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1057,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1057,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1057,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1057,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1057,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1058,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1058,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1059,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1059,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1060,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1060,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1061,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1061,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1061,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1061,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1061,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1062,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1063,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1064,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1065,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1065,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1066,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1067,1,Infected bite,Infections NEC,Infections - pathogen unspecified,Infec,N
1068,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1068,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1068,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1069,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1070,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
1070,2,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1070,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1071,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1072,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1072,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1073,1,Ingrown hair,Pilar disorders NEC,Skin appendage conditions,Skin,N
1074,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1075,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1075,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1076,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1077,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1078,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1078,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1079,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1079,2,Bile duct stone,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
1079,3,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1079,4,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1079,5,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1079,6,Gastrointestinal oedema,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1079,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1079,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1079,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1080,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1081,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1081,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1081,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1081,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1082,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1082,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1083,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1084,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1085,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1086,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1086,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
1087,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1088,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1089,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1090,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1091,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1091,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1091,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1091,4,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
1092,1,Blood iron abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1093,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1093,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1093,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1093,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1093,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1094,1,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1095,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1096,1,Bacterial test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
1096,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1096,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1097,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1097,2,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1098,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1098,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
1099,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1100,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1101,1,Headache,Headaches NEC,Headaches,Nerv,N
1102,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1103,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1103,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1104,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1105,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1106,1,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1106,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1107,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1108,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1109,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1110,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1111,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1112,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1113,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1114,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1115,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1116,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1116,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1116,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1117,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1118,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1119,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1119,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1120,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1120,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1121,1,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1121,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1121,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1121,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1122,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1123,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1124,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1124,2,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1124,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1125,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1125,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1126,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1127,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1127,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1127,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1128,1,Foot operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1129,1,Breast abscess,Breast infections,Infections - pathogen unspecified,Infec,N
1129,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1129,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1129,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1129,5,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1129,6,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1130,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1131,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1131,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1131,3,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1132,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1133,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1133,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1133,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1133,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1133,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1134,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1134,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1135,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1135,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1135,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1136,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1136,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1137,1,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1138,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
1138,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1138,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1138,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1138,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1139,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1140,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1140,2,Upper respiratory tract irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1141,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1141,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1142,1,Ligament rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1143,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1144,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1145,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1145,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1145,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1145,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1145,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1145,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1146,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1146,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1146,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1147,1,Headache,Headaches NEC,Headaches,Nerv,N
1147,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1147,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1147,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1148,1,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
1148,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1148,3,Spontaneous bacterial peritonitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1149,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1149,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1149,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1150,1,Infected bite,Infections NEC,Infections - pathogen unspecified,Infec,N
1150,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1151,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1151,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1152,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1152,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1153,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1154,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1154,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1155,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1155,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1156,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1157,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1157,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1157,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1158,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1158,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1159,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1159,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1159,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1159,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1160,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1160,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1161,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1162,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1162,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1162,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1163,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1164,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1164,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1164,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1165,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1165,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1165,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1166,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1167,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1168,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1168,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1169,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1170,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1170,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1171,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1172,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1173,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1173,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1173,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1174,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1175,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1175,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1176,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1177,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1177,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1177,3,Fungal foot infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1178,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1178,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1178,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1178,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1178,5,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1178,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1178,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1178,8,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1179,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1180,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1181,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1182,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1182,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1182,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1182,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1182,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1183,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1183,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1183,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1184,1,Headache,Headaches NEC,Headaches,Nerv,N
1184,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1185,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1185,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1185,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1186,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1186,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1187,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1188,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1189,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
1190,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1190,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1191,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1192,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1193,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1193,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1193,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1194,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1195,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1195,2,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1195,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1195,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1196,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1196,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1196,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1197,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1198,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1199,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1199,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1200,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1200,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1200,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1201,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1201,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1202,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1203,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1204,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1205,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1206,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1206,2,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1207,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1207,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1207,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1208,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1209,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1210,1,Administration site bruise,Administration site reactions NEC,Administration site reactions,Genrl,N
1210,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1211,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1211,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1211,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1211,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1212,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1212,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1213,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1213,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1213,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1214,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1214,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1214,3,Polychondritis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
1215,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1216,1,Injection related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1217,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1217,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1218,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1219,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1219,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1220,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1220,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1221,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1221,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1221,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1221,4,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1221,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1222,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1223,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1223,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1224,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1224,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1224,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1224,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1224,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1225,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1226,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1227,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1227,2,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
1228,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1228,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1229,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1230,1,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1231,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1232,1,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
1233,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1233,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1234,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1235,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1235,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1236,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1236,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1236,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1236,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1236,5,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1236,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1236,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1236,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1236,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1236,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1237,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1237,2,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1238,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
1239,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1240,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1240,2,Death,Death and sudden death,Fatal outcomes,Genrl,N
1240,3,Device failure,Device issues NEC,Device issues,Prod,N
1240,4,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1241,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1241,2,Device issue,Device issues NEC,Device issues,Prod,N
1241,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1242,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1242,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1243,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1244,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1245,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1246,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1246,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1247,1,Chronic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1248,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1249,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1249,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1250,1,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
1251,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1252,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1253,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1254,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1254,2,Cerebral fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1254,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1255,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1255,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1256,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1257,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1258,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1258,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1259,1,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1260,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1261,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1261,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1261,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1261,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1261,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1262,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1263,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1264,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1264,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1264,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1264,4,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1265,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1266,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1266,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1266,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1266,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1266,5,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1266,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1266,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1266,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1266,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1267,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1267,2,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1268,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1269,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1269,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1270,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1271,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1271,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1271,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1271,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1271,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1271,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1272,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1273,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1274,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1275,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1276,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1276,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1277,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1277,2,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1278,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1279,1,Autoinflammatory disease,Autoinflammatory diseases,Immune disorders NEC,Immun,N
1279,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1280,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1281,1,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1282,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
1282,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1282,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1283,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1283,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1283,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1283,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1283,5,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1284,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1284,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1284,3,Placental insufficiency,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1285,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1285,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1286,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1286,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1286,3,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
1286,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1287,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1287,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
1287,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1287,4,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1288,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1288,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1288,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1288,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1289,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1289,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1290,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1291,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1291,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1291,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1291,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1291,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1292,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1292,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1293,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1293,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1293,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1294,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1295,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1295,2,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1295,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1295,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1296,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1297,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1297,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1298,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1299,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1299,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1300,1,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1301,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1301,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1302,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1303,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1303,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1304,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1305,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1305,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1306,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1306,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1307,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1308,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1309,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
1310,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1310,2,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
1311,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1312,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1313,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1313,2,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,Y
1313,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1313,4,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1314,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1314,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1314,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1314,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1314,5,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1314,6,Immobile,Disability issues,Lifestyle issues,SocCi,N
1314,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1314,8,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1314,9,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1314,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1314,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1314,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1314,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1314,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1314,15,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1314,16,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1314,17,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1314,18,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1315,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1315,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1315,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1315,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1315,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1315,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1315,7,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1316,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1317,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1318,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1319,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1319,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1319,3,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1320,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1321,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1321,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1321,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1321,4,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
1321,5,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
1321,6,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1321,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1322,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1323,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1324,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1324,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1324,3,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1324,4,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1324,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1324,6,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1325,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1325,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1325,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1325,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1325,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1326,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1327,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1328,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1329,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
1329,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1329,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1329,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1330,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1330,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1331,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1331,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1331,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1331,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1332,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1332,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1332,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1333,1,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
1334,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1334,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
1335,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1336,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1336,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1336,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1336,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1336,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1336,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1336,7,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1336,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1337,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1337,2,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1337,3,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1337,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1337,5,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1338,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1338,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1338,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1338,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1339,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1339,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1339,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1339,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1340,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1340,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1341,1,Bacterial vulvovaginitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1341,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1341,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1341,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1341,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1341,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1342,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1342,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1342,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1343,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1343,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1344,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1345,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1346,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1347,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1347,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1347,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1347,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1347,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1348,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1349,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1350,1,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1350,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1351,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1351,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1351,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1351,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1352,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1352,2,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1353,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1354,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1354,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1355,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1355,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1355,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1356,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1356,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1357,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1357,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1357,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1357,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1357,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1358,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1358,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1358,3,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1358,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1358,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1359,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1360,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1360,2,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1361,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1361,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1362,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1363,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1364,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1364,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1364,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1364,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1364,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1365,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1365,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1365,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1365,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1366,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1367,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1367,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1368,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1369,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1369,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1369,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1370,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1370,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1370,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1370,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1370,5,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1370,6,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1371,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1372,1,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1373,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1373,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1374,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1374,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1375,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1376,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1377,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1378,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1378,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1379,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1380,1,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1381,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1381,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1382,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1382,2,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1383,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1384,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1384,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1384,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1385,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1386,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1387,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1387,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1388,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1389,1,Device failure,Device issues NEC,Device issues,Prod,N
1389,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1390,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1390,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1390,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1391,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1391,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1391,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1392,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1392,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1392,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1392,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1392,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1393,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1393,2,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
1393,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1394,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1395,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1395,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1395,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1395,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1396,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1397,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1398,1,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1398,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1398,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1399,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1399,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1400,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1401,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1401,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1402,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1403,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1403,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1403,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1404,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1404,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1405,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1405,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1406,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1407,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1407,2,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1407,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1407,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1407,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1407,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1407,7,Headache,Headaches NEC,Headaches,Nerv,N
1407,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1408,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1408,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1408,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1409,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1410,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1410,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1411,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1411,2,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1412,1,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1413,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1413,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1414,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1414,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1415,1,Calcinosis,Trophic disorders,Tissue disorders NEC,Genrl,N
1416,1,Drug delivery system issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1416,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1417,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1417,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1417,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1417,4,Headache,Headaches NEC,Headaches,Nerv,N
1417,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1417,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1417,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1417,8,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1418,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1419,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1419,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1420,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1421,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1421,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1422,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1422,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1422,3,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1422,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1423,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1424,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1424,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1424,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1425,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1425,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1426,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1427,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1427,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1428,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1428,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1428,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1428,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1429,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1430,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1430,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1430,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1430,4,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
1431,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1431,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1432,1,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
1433,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1434,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1435,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1436,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1436,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1436,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1437,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1438,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1439,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
1440,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1440,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1441,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1441,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1441,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1441,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1441,5,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
1441,6,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1442,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1442,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1442,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1443,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1444,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1444,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1444,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1444,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1444,5,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1444,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1444,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1444,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1445,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
1445,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1446,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1446,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1446,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1446,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1447,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1447,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1448,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1449,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1449,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1449,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1450,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1450,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1450,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1450,4,Headache,Headaches NEC,Headaches,Nerv,N
1450,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1450,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1450,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1450,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
1450,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1450,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1450,11,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1451,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1452,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1452,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1452,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1453,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1454,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1455,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1455,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1455,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1456,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1456,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1457,1,Phantom limb syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1458,1,Acne,Acnes,Skin appendage conditions,Skin,N
1458,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1458,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1458,4,Myopathy,Myopathies,Muscle disorders,Musc,N
1458,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1458,6,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1458,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1459,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1460,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1460,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1460,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1461,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1462,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
1462,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1462,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1462,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1462,5,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
1462,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1462,7,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1462,8,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
1462,9,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1462,10,Palate injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1463,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1463,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1464,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1465,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1465,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1465,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1466,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1466,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1466,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1466,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1467,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1468,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1468,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1468,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1468,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1468,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1468,6,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1469,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1470,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1471,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1472,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1472,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1472,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1472,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1473,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1474,1,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1475,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1476,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1476,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1477,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1478,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1479,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1479,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1480,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1481,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1482,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
1483,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1483,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1484,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1484,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1485,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1485,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1486,1,Dental care,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1486,2,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1487,1,Headache,Headaches NEC,Headaches,Nerv,N
1487,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1488,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1488,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1489,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1490,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1490,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1491,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1492,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1493,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1493,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1493,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1493,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1493,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1493,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1494,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1495,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1495,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1496,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1496,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1496,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1497,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1497,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1497,3,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1498,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1499,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1500,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1500,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1500,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1501,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1502,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1502,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1502,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1502,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1502,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1502,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1502,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1503,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1503,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1504,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1505,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1505,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1506,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1506,2,Headache,Headaches NEC,Headaches,Nerv,N
1506,3,Osteogenesis imperfecta,Non-site specific bone disorders congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1506,4,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
1507,1,Headache,Headaches NEC,Headaches,Nerv,N
1507,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1508,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1508,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1508,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1509,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1509,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1510,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1511,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1512,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1512,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1512,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1512,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1512,5,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1513,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1514,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1515,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1516,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1517,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1517,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1518,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1518,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1519,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1519,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1520,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1521,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1521,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1521,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1522,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1523,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1523,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1524,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1525,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1525,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1526,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1527,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1528,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1528,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1529,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1529,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1530,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1530,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1531,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1532,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1532,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1532,3,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1532,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1533,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1533,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1534,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1535,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1535,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1535,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1535,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1536,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
1536,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1536,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1537,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
1537,2,Secondary immunodeficiency,Acquired immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
1537,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1538,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1539,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1540,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1541,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1541,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1542,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1543,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1543,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1543,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1543,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1543,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1544,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1545,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1546,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1546,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1547,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1547,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1547,3,Headache,Headaches NEC,Headaches,Nerv,N
1547,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1547,5,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1548,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1548,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1548,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1548,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1549,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1549,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1550,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1551,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1551,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1552,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1553,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1554,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1554,2,Gastrointestinal injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1555,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1555,2,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1555,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1556,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1556,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1556,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1557,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1557,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1557,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1558,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1559,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1560,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1560,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1560,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1560,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1561,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1562,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1562,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1562,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1562,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1562,5,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1563,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1564,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1564,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1565,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1565,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1566,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1567,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1568,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1569,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1569,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1570,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1570,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1571,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1571,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1572,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1573,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1574,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1574,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1574,3,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1575,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1576,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1576,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1576,3,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1576,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1577,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1577,2,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1577,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1578,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1578,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1578,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1578,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1578,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1579,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1579,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1579,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1580,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1580,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1580,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1580,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1580,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1581,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1582,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1582,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1582,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1582,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1583,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1583,2,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1584,1,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1585,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1586,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1587,1,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1588,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1589,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1590,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1591,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1591,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1592,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1592,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1592,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1592,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1592,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1592,6,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1593,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1593,2,Headache,Headaches NEC,Headaches,Nerv,N
1593,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1593,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1593,5,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1594,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1595,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1595,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1595,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1595,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1595,5,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1596,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1597,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1597,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1598,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1599,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1599,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1600,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1600,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1601,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1602,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1603,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1603,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1603,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1603,4,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1603,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1603,6,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1603,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1604,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1605,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1606,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1606,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1607,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1608,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1609,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1609,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1610,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1611,1,Cerebral vasoconstriction,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1611,2,Cryptococcal meningoencephalitis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1611,3,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1611,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1611,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1611,6,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1611,7,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1611,8,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1612,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1612,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1613,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1613,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1614,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1615,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1615,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1615,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1615,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1615,5,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
1615,6,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1616,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1617,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1617,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1617,3,Migraine,Migraine headaches,Headaches,Nerv,N
1617,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1618,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1618,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1619,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1620,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1620,2,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1621,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1622,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1622,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1623,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1624,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1624,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1625,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1625,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1625,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1626,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1627,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1628,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1628,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1628,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1629,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1629,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1629,3,Device issue,Device issues NEC,Device issues,Prod,N
1629,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1629,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1629,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1630,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1631,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1632,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1633,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1634,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1635,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1636,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1636,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1637,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,Y
1638,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1638,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1638,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1639,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1639,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1640,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1640,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1640,3,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1641,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1641,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1641,3,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
1641,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1642,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1643,1,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1643,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1644,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1645,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1645,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1646,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1646,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1646,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1646,4,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
1647,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1648,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1648,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1649,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1650,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1651,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1652,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1653,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1654,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1654,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1654,3,Hepatic enzyme decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1654,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1655,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1656,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1656,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1657,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1658,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1659,1,Device failure,Device issues NEC,Device issues,Prod,N
1659,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1659,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1660,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1660,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1660,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1660,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1660,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1661,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1661,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1661,3,Headache,Headaches NEC,Headaches,Nerv,N
1661,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1661,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1661,6,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1661,7,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1662,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1662,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1663,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1664,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1665,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1666,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1666,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1667,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1667,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1668,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1669,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1670,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1670,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1671,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1671,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1671,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1672,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1672,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1673,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1673,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1674,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1674,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1674,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1675,1,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1675,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1676,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1677,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1678,1,Headache,Headaches NEC,Headaches,Nerv,N
1679,1,Chest injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
1679,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1679,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1679,4,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1679,5,Leg amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1679,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1680,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1680,2,Device issue,Device issues NEC,Device issues,Prod,N
1680,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1681,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1682,1,Headache,Headaches NEC,Headaches,Nerv,N
1683,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1683,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1684,1,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1685,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1686,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1686,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1686,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1686,4,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1687,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1687,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1687,3,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1688,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1688,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1688,3,Laziness,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1689,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1689,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1689,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1689,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1689,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1690,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1690,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1690,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1691,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1692,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1692,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1693,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1693,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1693,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1693,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1693,5,Headache,Headaches NEC,Headaches,Nerv,N
1693,6,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1693,7,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1693,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1694,1,Device issue,Device issues NEC,Device issues,Prod,N
1695,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1695,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1695,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1695,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1696,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1696,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1697,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1698,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1699,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1700,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1701,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1702,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1703,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1704,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1705,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1706,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1707,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1708,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1708,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1708,3,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1708,4,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1708,5,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
1708,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1708,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1708,8,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1708,9,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1708,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1708,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1708,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1708,13,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1708,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1708,15,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1708,16,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1709,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1710,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1711,1,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1712,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1712,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1713,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1713,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1713,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1713,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1714,1,Reversible cerebral vasoconstriction syndrome,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1715,1,Procedural anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1716,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1717,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1718,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1718,2,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
1719,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1719,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1719,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1719,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1719,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1720,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1720,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1721,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1721,2,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1722,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1722,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1722,3,Device failure,Device issues NEC,Device issues,Prod,N
1722,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1722,5,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1722,6,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1722,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1722,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1722,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1722,10,Pharyngeal exudate,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1723,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1724,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1724,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1724,3,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1724,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1725,1,Headache,Headaches NEC,Headaches,Nerv,N
1726,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1727,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1728,1,Drug delivery system issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1728,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1728,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1728,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1729,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1730,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1730,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1730,3,Headache,Headaches NEC,Headaches,Nerv,N
1730,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1730,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1731,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1731,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1732,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1733,1,Device failure,Device issues NEC,Device issues,Prod,N
1733,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1733,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1733,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1734,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1735,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1736,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1737,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1737,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1738,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1739,1,Dental operation,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1740,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1740,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1740,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1740,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1740,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1740,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1740,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1740,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1741,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1741,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1741,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1741,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1742,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1743,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1744,1,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1745,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1746,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1747,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1747,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1747,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1748,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1748,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1749,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1749,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1749,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1750,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1751,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1751,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1751,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1752,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1752,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1752,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1753,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1753,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1753,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1753,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1754,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1754,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1754,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1754,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1754,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1755,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1756,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1756,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1756,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1757,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1758,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1758,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1758,3,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
1758,4,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1758,5,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1759,1,Headache,Headaches NEC,Headaches,Nerv,N
1760,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1760,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1761,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1761,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1761,3,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1762,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1763,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1763,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1764,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1764,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1765,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1765,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1765,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1765,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1766,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1766,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1767,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1768,1,Dental operation,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1769,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1770,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1770,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1770,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1770,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1770,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1771,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1771,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1772,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1773,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1773,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1774,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1774,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1775,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1775,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1775,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1776,1,Dental operation,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1777,1,Device failure,Device issues NEC,Device issues,Prod,N
1777,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1777,3,Shoulder arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1778,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1779,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1780,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1780,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1781,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1782,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1782,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1782,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1783,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1783,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1784,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1784,2,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
1784,3,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1785,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1785,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1785,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1786,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1787,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1787,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1788,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1789,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1789,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1789,3,Pharyngeal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1789,4,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1790,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1790,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1791,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1792,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1793,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1793,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1793,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1794,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1794,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1794,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1795,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1795,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1795,3,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1795,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1795,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1795,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1795,7,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1795,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1796,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1796,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1796,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1797,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1798,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
1798,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1799,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1800,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1800,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1800,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1800,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1801,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1801,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1801,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1801,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1802,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1802,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1802,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1802,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1803,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1804,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1805,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1806,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1806,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1807,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1808,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1809,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1809,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1809,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1809,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1809,5,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
1810,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1811,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1812,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1812,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1812,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1812,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1813,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1813,2,Headache,Headaches NEC,Headaches,Nerv,N
1814,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1815,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1815,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1815,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1815,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1816,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1817,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1818,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1819,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1820,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1821,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1821,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1822,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1823,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1824,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1825,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1826,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1827,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1827,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1828,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1828,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1829,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1830,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1830,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1830,3,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1831,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1832,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1833,1,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1834,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1835,1,Infected bite,Infections NEC,Infections - pathogen unspecified,Infec,N
1836,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1836,2,Headache,Headaches NEC,Headaches,Nerv,N
1837,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1837,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1838,1,Nail infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1838,2,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1838,3,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1838,4,Tonsillitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1839,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1839,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1840,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1840,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1840,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1840,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1840,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1840,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1841,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1841,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1842,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1842,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1843,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1844,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1844,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1845,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1845,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1845,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1845,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1845,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1846,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1846,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1847,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1847,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1847,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1847,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1848,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1848,2,Ligament rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1848,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1849,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1849,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1850,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1850,2,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1851,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1852,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1852,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1852,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1852,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1853,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1853,2,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1853,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1854,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1854,2,Intercepted product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1855,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1855,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1856,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1856,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1856,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1857,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1858,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1859,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1860,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1860,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1861,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1862,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1862,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1862,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1862,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1863,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1864,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1865,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1865,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1865,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1866,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1867,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1867,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1867,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1867,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1868,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1868,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1868,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
